Electrical conditioning strategies in myocardial ischemia-reperfusion injury

Mark F A Bierhuizen1, Jorik H Amesz2, Olivier C Manintveld3

  • 1Translational Electrophysiology, Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Insights

Myocardial ischemia-reperfusion injury (IRI) causes heart damage after restoring blood flow post-infarction. Novel neuromodulation and electrical stimulation strategies show promise for cardioprotection against IRI.

Area of Science:

  • Cardiology
  • Physiology
  • Biomedical Engineering

Background:

  • Myocardial infarction (MI) care has improved, yet mortality remains high.
  • Ischemia-reperfusion injury (IRI) exacerbates myocardial damage after reperfusion.
  • Current cardioprotective strategies face challenges in clinical translation.

Purpose of the Study:

  • To review the molecular and electrical consequences of myocardial IRI.
  • To explore neuromodulation and electrical stimulation as novel cardioprotective strategies against IRI.

Main Methods:

  • Literature review of pre-clinical and clinical studies on IRI.
  • Analysis of molecular and electrical alterations in IRI.
  • Evaluation of conditioning strategies including neuromodulation and electrical stimulation.

Main Results:

  • IRI involves significant alterations in energy metabolism, ion homeostasis, and bioelectrical signaling.
  • Neuromodulation and electrical stimulation represent promising avenues for cardioprotection.
  • These approaches may offer alternative solutions to current clinical challenges in managing IRI.

Conclusions:

  • Understanding IRI's complex mechanisms is crucial for developing effective cardioprotection.
  • Neuromodulation and electrical stimulation warrant further investigation for clinical application in MI patients.
  • These innovative strategies could improve outcomes by mitigating IRI-induced myocardial damage.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
487
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
9.8K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
633